Background
Being diagnosed with cancer, irrespective of type initiates a serious psychological concern. The increasing rate of detection of indolent prostate cancers is a source of worry to public health. Digital rectal examination and prostate-specific antigen tests are the commonly used prostate cancer screening tests. Understanding the diagnostic accuracies of these tests may provide clearer pictures of their characteristics and values in prostate cancer diagnosis. This review compared the sensitivities and specificities of digital rectal examination and prostate-specific antigen test in detection of clinically important prostate cancers using studies from wider population.
Main body
We conducted literature search in PubMed, Medline, Science Direct, Wiley Online, CINAHL, Scopus, AJOL and Google Scholar, using key words and Boolean operators. Studies comparing the sensitivity and specificity of digital rectal examination and prostate-specific antigen tests in men 40 years and above, using biopsy as reference standard were retrieved. Data were extracted and analysed using Review manager (RevMan 5.3) statistical software. The overall quality of the studies was good, and heterogeneity was observed across the studies. The result comparatively shows that prostate-specific antigen test has higher sensitivity (P < 0.00001, RR 0.74, CI 0.67–0.83) and specificity (P < 0.00001, RR 1.81, CI 1.54–2.12) in the detection of prostate cancers than digital rectal examination.
Conclusion
Prostate-specific antigen test has higher sensitivity and specificity in detecting prostate cancers from men of multiple ethnic origins. However, combination of prostate-specific antigen test and standardized digital rectal examination procedure, along with patients history, may improve the accuracy and minimize over-diagnoses of indolent prostate cancers.
As the world goes through the fourth wave and the continued emergence of new COVID‐19 variants, the general and work‐related risks of healthcare professionals are expected to rise. This has the capacity to adversely affect productivity and efficiency in the healthcare delivery system, particularly in this era of global shortage of trained healthcare professionals. We aimed to develop and validate a new instrument known as the COVID‐19 Responses Impact Questionnaire (COVRiQ) to evaluate the impact of the pandemic on the healthcare professionals managing the COVID‐19 pandemic. This methodological study involved three steps: the formulation of the COVRiQ draft, content and face validation, and construct validity. A total of 61 questions were drafted with 3‐point Likert scale answers. From the list, 39 were rated valid by a panel of experts and subsequently tested on 301 participants. The results were analyzed and validated using exploratory factor analysis on SPSS. Components were extracted and questions with low factor loading were removed. The internal consistency was measured with Cronbach's alpha. Following analysis, three components were extracted and named as behavioral, social, and economic impacts. In general, 29 items were deleted leaving 32 out of 61 questions retained as the final validated COVRiQ. Internal consistency showed high reliability with Cronbach's alpha of 0.91. Participants scored a total cumulative mean of 118.74 marks. A subanalysis by occupation showed that medical assistants scored the lowest in the group with a score of 22.3% whereas medical specialists scored the highest at 77.7%. Higher score indicates higher impact of COVID‐19 responses among healthcare professionals. The new COVRiQ consisting of 32 items demonstrated to be user friendly with good psychometric properties and valid for assessing the impacts of COVID‐19 responses among healthcare professionals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.